Back    Zoom +    Zoom -
WUXI XDC Slumps ~5% on Reported Shareholder STA Pharmaceutical's Stake Cut at 6.5% Discount
Recommend
3
Positive
2
Negative
9
STA Pharmaceutical Hong Kong Investment, a shareholder of WUXI XDC (02268.HK), placed 30.3 million shares of WUXI XDC at HKD77.42 per share through Morgan Stanley, Bloomberg reported, citing filing. This represents a discount of nearly 6.5% compared to the closing price of HKD82.8 yesterday (8th).

WUXI XDC’s share price came under pressure today (9th), sliding as much as 5.4% to bottom at HKD78.3. It last traded at HKD78.85, down 4.8%, with a trading volume of 35.4038 million shares and a turnover of HKD2.751 billion.

Related NewsM Stanley Releases Latest Asian Thematic Focus List (Table)

AAStocks Financial News